
    
      Patients are randomized between the two treatment strategies mentioned above. After initial
      treatment the patients are categorized as palliative or treated with curative intent.
      Patients are followed with quality of life evaluations every 6 months. Outpatient visits,
      hospital care, examinations and treatment are recorded as well as complications and side
      effects. Survival is recorded and for those patients treated with curative intent the tumour
      situation 3 years after randomization is evaluated.
    
  